Attention deficit hyperactivity disorder

Active Ingredient: Clonidine

Indication for Clonidine

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Therapeutic intent: Curative procedure

Clonidine is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to central nervous system (CNS) stimulant medications in pediatric patients 6 years of age and older.

For this indication, competent medicine agencies globally authorize below treatments:

0.1 mg once daily followed by dose titration in increments of 0.1 mg per day at weekly intervals up to 0.4 mg once daily

For:

Dosage regimens

Oral, 0.1 milligrams clonidine, once daily at the end of the day, over the duration of 1 week. Afterwards, oral, between 0.1 milligrams clonidine and 0.4 milligrams clonidine, once daily at the end of the day. The maximum allowed total dose is 0.4 milligrams clonidine daily.

Detailed description

The starting dosage of clonidine is 0.1 mg orally once daily at bedtime with or without food. Titrate the dose of clonidine in increments of 0.1 mg per day at weekly intervals depending on clinical response up to the maximum recommended dosage of 0.4 mg once daily at bedtime.

Doses of clonidine higher than 0.4 mg once daily were not evaluated in clinical trials for ADHD and are not recommended.

When clonidine is added to a CNS stimulant, adjust the dose of the CNS stimulant depending on the clinical response to clonidine.

Discontinuation

When discontinuing clonidine, taper the total daily dose in decrements of no more than 0.1 mg every 3 to 7 days to avoid rebound hypertension.

Missed doses

If a dose of clonidine is missed, skip that dose and take the next dose as scheduled. Do not take more than the prescribed total daily amount of clonidine in any 24-hour period.

Dosage considerations

To be taken at bedtime with or without food.

Active ingredient

Clonidine

Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone.

Read more about Clonidine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.